Advances in Cholangiocarcinoma Treatment in the Personalized Medicine Era
Open Journal of Hepatology(2020)
Abstract
Cholangiocarcinoma is amongst the most common primary tumors of the liver, second only to hepatocellular carcinoma, and it accounts for approximately 15% of primary hepatic malignancies [1].
MoreTranslated text
Key words
cholangiocarcinoma treatment,personalized medicine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined